Hemorajik Şok ve Sıvı Replasman Tedavisi

Authors

Erdem Aksay

Synopsis

Hemorrhagic shock is a critical circulatory failure condition where tissue oxygen demand cannot be met, most commonly resulting from intravascular volume loss following trauma. Classified into four clinical stages based on the amount of blood loss and the body's compensatory response, hemorrhagic shock presents with clinical findings such as tachycardia, hypotension, tachypnea, decreased urine output, confusion, and elevated serum lactate levels. As shock progresses, cellular damage deepens, potentially leading to the lethal triad consisting of coagulopathy, metabolic acidosis, and hypothermia. The primary objective of treatment is to achieve hemorrhage control, restore tissue perfusion, and maintain a mean arterial pressure above 65 mmHg. The initial agents of choice for fluid replacement therapy are inexpensive, safe, and effective crystalloid solutions such as isotonic sodium chloride or Lactated Ringer's; however, since these fluids have a low intravascular retention rate, administering three times the estimated blood loss is recommended. In cases of severe blood loss and non-responsive patients, blood products and massive transfusion protocols utilizing red blood cells, fresh frozen plasma, and platelets in equal ratios (1:1:1) should be initiated. Throughout the treatment process, the patient's mental status, vital signs, urine output, central venous pressure, and lactate levels must be closely monitored to evaluate resuscitation efficacy, while ensuring prompt hemostasis and surgical consultation.

References

Tintinalli, J.E. (2013). Şoktaki Hastaya Yaklaşım, Sıvı ve Kan Resusitasyonu. (Cem ERTAN, Cüneyt AYRIK, Ulaş KARAASLAN, Evern UYGUNGÜL, Çev. Ed.), Acil Tıp Kapsamlı Bir Çalışma Klavuzu (165- 177) İstanbul: Nobel Tıp Kitabevi

Astiz ME, Rackow EC: Septic shock. Lancet 1998;351:1501-1505

Blalock A: Shock and other problems, Principles of Surgical Care, St Louis, 1940, Mosby

Cander, B. (2020). Şok. Yavuz Katırcı(Ed), Acil Tıp Temel Başvuru Kitabı 367- 381) İstanbul: İstanbul Tıp Kitabevleri

Satar, S. (2016). Şok. Yusuf Ali Altuncu (Ed), Acilde Kardiyoloji (185-204), Adana: Çukurova Nobel Tıp Kitabevi

Capone AC, Safar P, Stezoski W, et al: Improved Outcome With Fluid Restriction in Treatment Of Uncontrolled Hemorrajic Shock, J Am Coll Surg 1995;180:49-56

Burris D, Rhee P, Kaufmann C, et al: Controlled Resusitation for Uncontrolled Hemorrhagic Shock, J Trauma 1999;46:216-23

Bickell WH, Wall MJ, Pepe, et al: Immediate Versus Delayed Fluid Resuscitation For Hypotensive Patients with Penetrating Torso Injuries, N Engl J Med, 1994;331:1105-9

Heron M. Deaths: Leading Causes for 2016. Natl Vital Stat Rep. 2018;67(6):1-77 [PubMed]

Roberts I, Ewans P, Bunn F, et al: Is The Normalisation Of Blood Pressure In Bleeding Trauma Patients Harmful? Lancet 2001; 357-87

Bellamy RF, Maningas PA, Wenger BA: Current Shock Models and Clinical, Correliations. Ann Emerg Med. 1986;15:1392

Trauma. Mullins RJ. Management of Shock, Mattox KL, Feliciano.DV, Moore EE., Trauma, Vol. 11 The Gut as a Cytokine-Generating Organ In Rats Subjected To Hemorrhagic Shock, 1994;1:141-5

Lucas CE., Update on Trauma in Canada, Resuscitation Though The Three Phase of Hemorrhagic Shock After Trauma, Can J Surg 1990;33:451

Mizushima Y , Tohira H, Mizobata Y, et al. Fluid Resuscitation of Trauma Patients: How fast is the optimal rate? Am J Emerg Med 2005;23:833-837

Deane SA, Gaudry PL, Woods P, Cass D, Hollands MJ, Cook RJ, Read C. The Management Of Injuries - A Review of Deaths in Hospital, Aust N Z J Surg. 1988 Jun;58(6):463-9

Boldt J. Fluid Choices For Resuscitation In Trauma, International Trauma Care (ITACCS)2008;18:57-65

Guly HR, Bouamra O, Spiers M, Dark P, Coats T, Lecky FE. Vital Signs and Estimated Blood Loss in Patients with Major Trauma: Testing The Validity of The ATLS Classification of Hypovolaemic Shock, 2011;82(5):556-559. doi:10.1016/j.resuscitation.2011.01.013

Dutton RP., Current Concepts in Hemorrhagic Shock. A. 2007;25(1):23-34. doi:10.1016/j.atc.2006.11.007

Smith JB, Pittet J-F, Pierce A., Hypotensive Resuscitation. C. 2014;4(3):209-215. doi:10.1007/s40140-014-0064-7

Lenz A, Franklin GA, Cheadle WG. Systemic Inflammation After Trauma. I. 2007;38(12):1336-1345. doi:10.1016/j.injury.2007.10.003

Bedreag OH, Papurica M, Rogobete AF, et al. New Perspectives Of Volemic Resuscitation In Polytrauma Patients: A Review. B. 2016;4(1). doi:10.1186/s41038-016-0029-9

Keel M, Trentz O., Pathophysiology of Polytrauma. I. 2005;36(6):691-709. doi:10.1016/j.injury.2004.12.037

Dutton RP. , Haemostatic Resuscitation. B. 2012;109:i39-i46. doi:10.1093/bja/aes389

MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M. Early Coagulopathy Predicts Mortality in Trauma. T. 2003;55(1):39-44. doi:10.1097/01.ta.0000075338.21177.ef

Holcomb JB. Damage Control Resuscitation. T. 2007;62(Supplement):S36-S37. doi:10.1097/ta.0b013e3180654134

Cosgriff N, Moore E, Sauaia A, Kenny-Moynihan M, Burch J, Galloway B., Predicting Life-Threatening Coagulopathy in The Massively Transfused Trauma Patient: Hypothermia and Acidoses Revisited. J Trauma. 1997;42(5):857-61; discussion 861-2. [PubMed]

Spinella PC, Holcomb JB. Resuscitation and Transfusion Principles for Traumatic Hemorrhagic Shock. B. 2009;23(6):231-240. doi:10.1016/j.blre.2009.07.003

Kirkman E, Watts S. Haemodynamic Changes in Trauma. B. 2014;113(2):266-275. doi:10.1093/bja/aeu232

Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: Its Pathophysiology and Treatment in the Injured Patient. W. 2007;31(5):1055-1065. doi:10.1007/s00268-006-0653-9

Gann DS, Drucker WR. Hemorrhagic Shock. J. 2013;75(5):888-895. doi:10.1097/ta.0b013e3182a686ed

Andreason CL, Pohlman TH. Damage Control Resuscitation for Catastrophic Bleeding. O. 2016;28(4):553-568. doi:10.1016/j.coms.2016.06.010

Hardy J-F, de Moerloose P, Samama CM. The Coagulopathy of Massive Transfusion. V. 2005;89(3):123-127. doi:10.1111/j.1423-0410.2005.00678.x

Tümay V, Toktay R. Hipovolemik Şok. Yoğun Bakım Dergisi. 2002; 2:246-54

Deitch EA, Dayal SD. Intensive Care Unit Management of The Trauma Patient. Crit Care Med 2006;34:2294-301

Andrew M. Schulman, Jeffrey A. Claridge, , Gordon Carr, BA, Diana L. Diesen, BA, and Jeffrey S. Young,. Predictors of Patients Who Will Develop Prolonged Occult Hypoperfusion Following Blunt Trauma. J Trauma. 2004;57:795–800.

Samuel A. Tisherman, MD Trauma Fluid Resuscitation in 2010 The Journal of Trauma Injury, Infection, and Critical Care

Marcelo Augusto Fontenelle Ribeiro Jr, Marina Gabrielle Epstein, Luciana Daniela Lossurdo De Araujo Alves Volume Replacement in Traumaturkish Journal Of Trauma & Emergency Surgery 2009;15(4):311-316

Sheldon GF, Watkins GM, Glover JL, Greenburg AG, Friedman BA. Panel: "Present Use of Blood and Blood Products". J Trauma. 1981; 21:1005-12.

Bellomo R, Morimatsu H, French C, Cole L, Story D, Uchino S, et al. Safe Study Investigators, The Effects of Saline or Albumin Resuscitation on Acid-Base Status snd Serum Electrolytes. Crit Care Med. 2006; 34:2891-7.

Matheson NA, Diomi P. Renal failure After The Administration of Dextran 40. Surg Gynecol Obstet. 1970; 131;661-8.

Wilkes MM, Navickis RJ. Patient Survival After Human Albümin Administration A Meta-Analysis Of Randomized, Controlled Trials. Ann Intern Med. 2001; 135:149-64.

Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM. A Prospective Randomized Study of Hydroxyethyl Starch, Albumin, and Lactated Ringer's Solution As Priming Fluid for Cardiopulmonary Bypass. J Thorac Cardiovasc Surg. 1985; 89:713-22.

Çakmakçı M, Sayek _. Sok. Sayek _ (ed). Temel Cerrahi, III. Baskı. Ankara Günes Kitabevi 177-187, 2004.

Luiz CV Bahten, Fernando HO Mauro, Maria F Domingos, Paula H Scheffer, Bruno H Pagnoncelli and Marco AR Wille Endocrine and Metabolic Response to Trauma in Hypovolemic Patients Treated At A Trauma Center in BrazilWorld Journal of Emergency Surgery 2008, 3:28

Pages

41-48

Published

May 31, 2021

License

License